Carol practices in the firm's Washington, D.C. office.
Carol has extensive regulatory, investigatory and litigation expertise across a broad range of health care, life sciences, and other government-regulated industries. She represents entities involved in a variety of investigation and enforcement actions, including: federal, state, and global civil, criminal, and regulatory enforcement and compliance matters involving the Department of Justice, U.S. Attorney's Office, Food and Drug Administration, Securities and Exchange Commission, HHS Office of Inspector General, and State Attorneys General.
She has represented entities in: fraud investigations; False Claims Act litigation and internal investigations; Foreign Corrupt Practices Act and anti-bribery/corruption investigations, due diligence and compliance; FDA enforcement and compliance issues; clinical research compliance; NIH grant compliance and enforcement; and HIPAA Privacy issues. Carol also counsels, advises, and represents organizations on policy and governance issues, crisis management, emerging legal developments, and regulatory compliance issues.
Carol holds a number of leadership positions including serving as Vice-Chair of the ABA Health Law Section's Sponsorship Committee, and is Past Chair of the ABA Health Law Section Fraud and Abuse Interest Group and Past Vice-Chair of the American Health Lawyers Association Fraud & Abuse Practice Group.
Carol has authored numerous articles and frequently speaks at national and international conferences on fraud and abuse, Foreign Corrupt Practice Act and Anti-Corruption issues, the False Claims Act, clinical research compliance, NIH grant fraud and abuse issues, internal investigations and various other topics.